A Danish study on 159 type 2 diabetes melitus (T2DM) patients concluded that SLC22A1 polymorphisms decrease the steady state of metformin and are associated with a reduction in the absolute decrease in Hb1Ac [39]. Here, SLC22A1 is linked to type 2 diabetes mellitus.